Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Xylem Q4 Adj. EPS $0.99 Beats $0.96 Estimate, Sales $2.12B Beat $2.05B Estimate

Author: Benzinga Newsdesk | February 06, 2024 07:57am
Xylem (NYSE:XYL) reported quarterly earnings of $0.99 per share which beat the analyst consensus estimate of $0.96 by 3.13 percent. This is a 7.61 percent increase over earnings of $0.92 per share from the same period last year. The company reported quarterly sales of $2.12 billion which beat the analyst consensus estimate of $2.05 billion by 3.32 percent. This is a 40.64 percent increase over sales of $1.51 billion the same period last year.

Posted In: XYL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist